Human ex vivo carcinoma cells produce transforming growth factor β and thereby can inhibit lymphocyte functions in vitro F. VánkyNoémi NagyEva Klein ORIGINAL ARTICLE 01 February 1997 Pages: 317 - 323
Tumor cell reactivity mediated by IgM antibodies in sera from melanoma patients vaccinated with GM2 ganglioside covalently linked to KLH is increased by IgG antibodies P. LivingstonShengle ZhangMartin Fleisher ORIGINAL ARTICLE 01 February 1997 Pages: 324 - 330
Distinct biological activities of recombinant forms of human interleukin-2 in vivo A. B. LentschKoji NakagawaMichael J. Edwards ORIGINAL ARTICLE 01 February 1997 Pages: 331 - 336
Nucleosome-dependent escape of tumor cells from natural-killer-mediated lysis: nucleosomes are taken up by target cells and act at a postconjugation level A.-D. Le Lann-TerrisseGilbert Jean FourniéHervé Benoist ORIGINAL ARTICLE 01 February 1997 Pages: 337 - 344
Contrasting effects of T cell growth factors on T cell responses to melanoma in vitro T. D. NguyenMelanie J. SmithPeter Hersey ORIGINAL ARTICLE 01 February 1997 Pages: 345 - 354
A survivor of breast cancer with immunity to MUC-1 mucin, and lactational mastitis Keith R. JeromeAllan D. KirkO. J. Finn ORIGINAL ARTICLE 01 February 1997 Pages: 355 - 360
In vivo antitumor effects of murine interferon- γ -inducing factor/interleukin-18 in mice bearing syngeneic Meth A sarcoma malignant ascites M. J. MicallefKenshi YoshidaMasashi Kurimoto ORIGINAL ARTICLE 01 February 1997 Pages: 361 - 367
Regulation of proliferation of UM-SCV-1A and UM-SCV-6 vulvar carcinoma cells by cytokines K. VihkoMarjo SeppänenReijo Punnonen ORIGINAL ARTICLE 01 February 1997 Pages: 368 - 374
Th2-like response and antitumor effect of anti-interleukin-4 mAb in mice bearing renal cell carcinoma T. TakeuchiTetsuo UekiKazuki Kawabe ORIGINAL ARTICLE 01 February 1997 Pages: 375 - 381
